About Donald Milder
Donald Milder is a director at Okami Medical.
Donald Milder reports to the SEC as a director or major shareholder of 10 public companies, including Inari Medical (NARI), Flexion Therapeutics (FLXN) and Glaukos (GKOS).
Donald Milder first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Donald Milder in the role, so the role may have started earlier or lasted longer.
II
Inari Medical, Inc.
Director and 10% owner
2020 – 2025 · Public company (NARI)
FI
Flexion Therapeutics Inc
Director and 10% owner
2014 – 2016 · Public company (FLXN)
GC
Glaukos Corp.
10% owner
2015 – 2016 · Public company (GKOS)
PI
Phaserx, Inc.
10% owner
2016 · Public company (PZRX)
II
Inogen Inc
10% owner
2014 – 2015 · Public company (INGN)
VI
Vivani Medical, Inc.
10% owner
2014 · Public company (VANI)
HC
Helicos Biosciences Corp.
10% owner
2007 – 2009 · Public company (HLCS)
IC
Insulet Corp.
10% owner
2007 · Public company (PODD)
PI
Paratek Pharmaceuticals, Inc.
10% owner
2006 · Public company (PRTK)
AI
Alexza Pharmaceuticals Inc.
10% owner
2006 · Public company (ALXA)
Key Colleagues at Startups
The people Donald Milder works with at each company, as listed on that company's latest Form D.
Okami Medical, Inc. · Form D, Dec 1, 2025
RR
Robert Rosenbluth
Director
JR
Jonathan Root
Director
MK
Mike Kramer
Director
WH
William Hoffman
Director
AH
Andrew Hykes
Chief Executive Officer and director
KN
Kirk Nielsen
Director
PL
Paul Lubock
Director